Corbus Pharmaceuticals Holdings, Inc. (CRBP)
After hours:
| Previous close | 51.58 |
| Open | 51.75 |
| Bid | 55.35 x 100 |
| Ask | 55.86 x 200 |
| Day's range | 51.75 - 56.47 |
| 52-week range | 3.03 - 61.90 |
| Volume | |
| Avg. volume | 299,303 |
| Market cap | 672.17M |
| Beta (5Y monthly) | 2.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Corbus Pharmaceuticals Holdings, Inc. (CRBP): This Small-Cap Healthcare Stock Is A Good Buy Right Now
We recently compiled a list of the 10 Best Small-Cap Healthcare Stocks To Buy Now. In this article, we are going to take a look at where Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) stands against the other small-cap healthcare stocks. Healthcare Sector: A Defensive Investment with Growth Potential in 2024 In difficult economic times, healthcare equities are […]
- Insider Monkey
Corbus Pharmaceuticals Holdings, Inc. (CRBP): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
We recently compiled a list of the Oppenheimer’s Favorite Stocks For Next 12 Months: Top 32 Stock Picks. In this article, we are going to take a look at where Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) stands against Oppenheimer’s other favorite stocks for the next 12 months. The tail end of August is appearing to turn […]
- Zacks
Wall Street Analysts Think Corbus Pharmaceuticals (CRBP) Could Surge 43.82%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 43.8% in Corbus Pharmaceuticals (CRBP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
